by Tony Dammicci | Sep 20, 2023 | Press Releases
Shares to Begin Trading on NASDAQ on September 21, 2023 Under the Ticker Symbol “MDBH” ADDISON, TX / ACCESSWIRE / September 20, 2023 / MDB Capital Holdings, LLC, (NASDAQ:MDBH) (“MDB”), a public venture platform with the objective of growing the...
by Tony Dammicci | Sep 8, 2023 | Press Releases
The presentation included herein is a free writing prospectus and is an offer to purchase Class A Common Shares of MDB Capital Holdings, LLC (the ”Company”) in a public offering of securities of the Company. The Company has filed with the Securities and Exchange...
by Tony Dammicci | Aug 7, 2023 | Press Releases
The presentation included herein is a free writing prospectus and is an offer to purchase Class A Common Shares of MDB Capital Holdings, LLC (the ”Company”) in a public offering of securities of the Company. The Company has filed with the Securities and Exchange...
by Tony Dammicci | Mar 15, 2023 | Press Releases
Paris and Red Bank, N.J. March 13, 2023 Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), have entered into an agreement under...
by Jim Foley | Nov 29, 2022 | Press Releases
DALLAS, T.X. / ACCESSWIRE / November 29, 2022 / MDB Capital Holdings, LLC, a privately-held public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, today announced that...
by Jim Foley | Nov 17, 2022 | Press Releases
DALLAS, TX / ACCESSWIRE / November 17, 2022 / Public Ventures, LLC, a wholly owned subsidiary of MDB Capital Holdings, LLC, completed its first financing as a broker-dealer for Cue Biopharma, Inc. (NASDAQ:CUE). The Public Ventures’ portion of the financing was...
Recent Comments